跳至主要内容
临床试验/CTRI/2025/08/093355
CTRI/2025/08/093355尚未招募3 期

To Evaluate The Effectiveness Of Individualized Homoeopathic Medicines Vs Chrysarobinum For The Treatment Of Dermatophytosis: A Randomized Controlled Clinical Trial

Dr Aishwarya Shukla1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月1日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
The study is expected to yield better therapeutic results with Individualized homoeopathic

研究概览

简要总结

This study compares the effectiveness of Individualized Homeopathic Medicines and Chrysarobinum in treating patients with Dermatophytosis, aged 18-60 years. Patients will be randomly assigned to receive either Individualized homeopathic medicines or Chrysarobinum. The study will measure the improvement by clinical assessment of the lesion with photographic evidence, Peak Pruritus Numeric Rating Scale (PP-NRS), Dermatological Life Quality Index scores and by observing changes in fungal load on potassium hydroxide (KOH) microscopic examination. The primary goal is to compare the efficacy of these two approaches in managing Dermatophytosis, improving quality of life, and reducing disease severity. The results will provide valuable insights into the effectiveness of Homeopathic approaches in treating Dermatophytosis.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Patient suffering from Dermatophytosis based on clinical presentation of lesions.
  • Desirable – evidence of presence of fungal hyphae, spores on microscopic examination on KOH wet mount.
  • Both sexes of age group 18 years to 65 years.
  • Not using any systemic/ topical antifungal treatment for past 2 weeks.
  • Patient who are willing for regular follow-ups.

排除标准

  • Dermatophytosis patients suffering from any life-threatening illness who are terminally ill, under immuno-suppressive treatment or self-reported immuno-compromised state.
  • Patients of malignancy or too sick for consultation.
  • Diagnosed case of mental illness / psychiatric/ other uncontrolled/ life threatening conditions.
  • Patients taking any other mode of treatment.
  • Pregnant and lactating mothers.
  • Substance abuse and or dependence.

结局指标

主要结局

The study is expected to yield better therapeutic results with Individualized homoeopathic

时间窗: 1 year (12 months)

medicines as compared to Chrysarobinum in treatment of dermatophytosis.

时间窗: 1 year (12 months)

次要结局

  • 1. This study anticipates improvements in itching severity and quality of life among patients receiving homoeopathic medicines as reflected by improved scores on the Peak Pruritus(Numeric Rating Scale and the Dermatology Life Quality Index (DLQI).)

研究者

发起方
Dr Aishwarya Shukla
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Aishwarya Shukla

Dr B R Sur Homoeopathic Medical College, Hospital And Research Centre

研究点 (1)

Loading locations...

相似试验